TY - JOUR
T1 - The Optimal Timing of Stage-2-Palliation After the Norwood Operation
AU - for the
AU - Congenital Heart Surgeons’ Society Timing of S2P Working Group
AU - Meza, James M.
AU - Hickey, Edward
AU - McCrindle, Brian
AU - Blackstone, Eugene
AU - Anderson, Brett
AU - Overman, David
AU - Kirklin, James K.
AU - Karamlou, Tara
AU - Caldarone, Christopher
AU - Kim, Richard
AU - DeCampli, William
AU - Jacobs, Marshall
AU - Guleserian, Kristine
AU - Jacobs, Jeffrey P.
AU - Jaquiss, Robert
N1 - Publisher Copyright:
© 2018 The Society of Thoracic Surgeons
PY - 2018/1
Y1 - 2018/1
N2 - Background The effect of the timing of stage-2-palliation (S2P) on survival through single ventricle palliation remains unknown. This study investigated the optimal timing of S2P that minimizes pre-S2P attrition and maximizes post-S2P survival. Methods The Congenital Heart Surgeons’ Society's critical left ventricular outflow tract obstruction cohort was used. Survival analysis was performed using multiphase parametric hazard analysis. Separate risk factors for death after the Norwood and after S2P were identified. Based on the multivariable models, infants were stratified as low, intermediate, or high risk. Cumulative 2-year, post-Norwood survival was predicted. Optimal timing was determined using conditional survival analysis and plotted as 2-year, post-Norwood survival versus age at S2P. Results A Norwood operation was performed in 534 neonates from 21 institutions. The S2P was performed in 71%, at a median age of 5.1 months (IQR: 4.3 to 6.0), and 22% died after Norwood. By 5 years after S2P, 10% of infants had died. For low- and intermediate-risk infants, performing S2P after age 3 months was associated with 89% ± 3% and 82% ± 3% 2-year survival, respectively. Undergoing an interval cardiac reoperation or moderate-severe right ventricular dysfunction before S2P were high-risk features. Among high-risk infants, 2-year survival was 63% ± 5%, and even lower when S2P was performed before age 6 months. Conclusions Performing S2P after age 3 months may optimize survival of low- and intermediate-risk infants. High-risk infants are unlikely to complete three-stage palliation, and early S2P may increase their risk of mortality. We infer that early referral for cardiac transplantation may increase their chance of survival.
AB - Background The effect of the timing of stage-2-palliation (S2P) on survival through single ventricle palliation remains unknown. This study investigated the optimal timing of S2P that minimizes pre-S2P attrition and maximizes post-S2P survival. Methods The Congenital Heart Surgeons’ Society's critical left ventricular outflow tract obstruction cohort was used. Survival analysis was performed using multiphase parametric hazard analysis. Separate risk factors for death after the Norwood and after S2P were identified. Based on the multivariable models, infants were stratified as low, intermediate, or high risk. Cumulative 2-year, post-Norwood survival was predicted. Optimal timing was determined using conditional survival analysis and plotted as 2-year, post-Norwood survival versus age at S2P. Results A Norwood operation was performed in 534 neonates from 21 institutions. The S2P was performed in 71%, at a median age of 5.1 months (IQR: 4.3 to 6.0), and 22% died after Norwood. By 5 years after S2P, 10% of infants had died. For low- and intermediate-risk infants, performing S2P after age 3 months was associated with 89% ± 3% and 82% ± 3% 2-year survival, respectively. Undergoing an interval cardiac reoperation or moderate-severe right ventricular dysfunction before S2P were high-risk features. Among high-risk infants, 2-year survival was 63% ± 5%, and even lower when S2P was performed before age 6 months. Conclusions Performing S2P after age 3 months may optimize survival of low- and intermediate-risk infants. High-risk infants are unlikely to complete three-stage palliation, and early S2P may increase their risk of mortality. We infer that early referral for cardiac transplantation may increase their chance of survival.
UR - http://www.scopus.com/inward/record.url?scp=85028338974&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2017.05.041
DO - 10.1016/j.athoracsur.2017.05.041
M3 - Article
C2 - 28847537
AN - SCOPUS:85028338974
SN - 0003-4975
VL - 105
SP - 193
EP - 199
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 1
ER -